semaglutide cardiovascular outcomes news today SELECT Trial Evaluating the Cardiovascular Benefits of

According to a recent survey of over 1,000 GLP-1 users, many people are noticing significant changes in their relationship with alcohol, drugs, and impulsive behaviors

Starting December of 2025, its also approved as a daily pill

When administered professionally, it not only lightens the skin but also enhances overall skin health by repairing damaged cells and fighting free radicals

Book Now Cagrilintide Peptide (10 mg vial) infusion from AMIV helps regulate appetite, support weight loss, and improve overall metabolic health

While nausea and vomiting are more common with short-acting agents, side effects such as itching or nodules at the injection site are more common with long-acting agents and usually disappear in 3 to 4 weeks